Literature DB >> 14574296

Matrix metalloproteinases in a gerbil cholesteatoma model.

Jason G Wilmoth1, Gregory S Schultz, Patrick J Antonelli.   

Abstract

OBJECTIVE: The goal of this study was to determine whether expression of matrix metalloproteinases (MMP) and tumor necrosis factor-alpha (TNF-alpha) occurs in a gerbil cholesteatoma model, which may be involved early in the pathogenesis of cholesteatoma. Study design Atelectasis was induced by transpalatal, bilateral Eustachian tube obstruction on gerbil ears (n = 60). Tympanic membranes were removed at days 0, 3, 7, 14, 28, 56, and 84, and quantitative analysis of TNF-alpha and MMPs was performed.
RESULTS: Atelectasis and middle ear inflammation increased with time. TNF-alpha and MMP levels increased (P < 0.0083) with time, inflammation, and atelectatic stage with some variability seen between different MMPs.
CONCLUSION: Elevation of TNF-alpha and MMPs associated with progressive tympanic membrane atelectasis suggests a possible role for these inflammatory mediators in the pathogenesis of cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574296     DOI: 10.1016/S0194-59980301317-2

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   5.591


  3 in total

1.  Activities of matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in idiopathic hemotympanum and otitis media with effusion.

Authors:  Sung K Moon; Fred H Linthicum; Hae Dong Yang; Seung Joo Lee; Keehyun Park
Journal:  Acta Otolaryngol       Date:  2008-02       Impact factor: 1.494

2.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

Review 3.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.